- Article
An In Vitro Examination of Whether Kratom Extracts Enhance the Cytotoxicity of Low-Dose Doxorubicin against A549 Human Lung Cancer Cells
- Asep Bayu,
- Siti Irma Rahmawati,
- Firmansyah Karim,
- Jonathan Ardhianto Panggabean,
- Dasilva Primarindu Nuswantari,
- Dwi Wahyu Indriani,
- Peni Ahmadi,
- Rendi Witular,
- Ni Luh Putu Indi Dharmayanti and
- Masteria Yunovilsa Putra
Doxorubicin is an effective chemotherapeutic agent in the treatment of solid hematological and non-hematological carcinoma. However, its long-term usage could result in side effects, such as cardiomyopathy, chronic heart failure, neurotoxicity and ca...

